Integra Lifesciences Holdings's accounts payable is $88M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), IART shows a accounts payable of $88M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, IART's accounts payable is now $88M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Integra Lifesciences Holdings is outperforming or lagging.
Tracking IART's accounts payable over time shows whether Integra Lifesciences Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $88M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this accounts payable page, Stockcircle has Integra Lifesciences Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $88M) with ownership activity and broader fundamentals.
Integra Lifesciences Holdings's accounts payable is $88M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.